Immune Probiotic Strains Guide — Evidence-Based Strains, Dosing Protocols & Research Database

HealthSecrets.com Evidence-Based GitHub Pages

← Back to all resources

> **🔬 Quick Answer — Which Probiotic Strains Actually Strengthen Your Immune System?** > > - **Probiotics reduce upper respiratory infections by 47%** — a 2015 Cochrane review of 12 RCTs found significant reductions in infection incidence, duration, and antibiotic use [1] > - **LGG (Lactobacillus rhamnosus GG) is the most-studied immune probiotic strain**, with 40+ clinical trials showing enhanced IgA production, macrophage activation, and reduced respiratory infection rates [2] > - **B. lactis BB-12 enhances NK cell activity and vaccine responses** in both healthy adults and elderly populations, making it the top Bifidobacterium for immune support [3] > - **Strain specificity matters** — immune benefits are strain-specific, not species-wide. This guide covers 7 clinically validated strains with dosing protocols for children, adults, elderly, and athletes

Your gut houses roughly 70% of your entire immune system — a sprawling network of immune cells, antibody-producing tissue, and microbial communities that constantly communicate to keep you healthy. Probiotics tap directly into this gut-immune axis, and the clinical evidence for specific strains has grown remarkably strong over the past decade.

But here’s what most probiotic guides get wrong: they treat all strains as interchangeable. They’re not. Lactobacillus rhamnosus GG enhances mucosal immunity through entirely different pathways than Saccharomyces boulardii stimulates intestinal immunoglobulin A. Choosing the right strain — at the right dose, for the right person — is the difference between measurable immune improvement and expensive urine.

This resource page is built on the comprehensive research from our probiotics for immune health guide, reorganized as a quick-reference database with strain comparison tables, population-specific dosing protocols, product selection criteria, and a curated PubMed citation database.

How does this differ from our Immune System Science Toolkit? That page ranks all 15 immune strategies and covers supplements broadly. This guide goes deep on probiotics specifically — individual strain profiles, head-to-head evidence comparisons, and precise dosing by population.

Table of Contents

Which Probiotic Strains Have the Strongest Evidence for Immune Support?

Seven probiotic strains stand out from the clinical literature with robust evidence for immune modulation — each with distinct mechanisms, evidence strength, and population-specific benefits. The table below ranks them by overall clinical evidence quality, from the most extensively studied to those with promising but more limited human trial data.

Rank Strain Evidence Grade Primary Immune Mechanism Key Clinical Finding Best For
1 Lactobacillus rhamnosus GG (LGG) A Enhances IgA, activates macrophages, strengthens gut barrier Reduced respiratory infections in children by 34% (Hojsak et al., 2010) [2] Children, general immunity
2 Bifidobacterium animalis subsp. lactis BB-12 A Increases NK cell activity, enhances phagocytosis, improves vaccine response Enhanced influenza vaccine antibody response in elderly (Akatsu et al., 2013) [3] Elderly, vaccine support
3 Bifidobacterium animalis subsp. lactis HN019 A Boosts NK cell and neutrophil activity, anti-inflammatory Significant increase in NK cell activity within 3 weeks (Gill et al., 2001) [4] Elderly, age-related decline
4 Bifidobacterium animalis subsp. lactis Bl-04 B+ Modulates antiviral innate responses, enhances macrophage/DC cytokines 27% reduction in URTI risk in physically active adults (West et al., 2014) [5] Athletes, active adults
5 Saccharomyces boulardii CNCM I-745 A Stimulates intestinal IgA, modulates gut immune signaling 4.4-fold increase in anti-toxin A IgA levels; 84% efficacy across 27 RCTs [6][7] Gut immunity, travel
6 Lactobacillus plantarum 299v B Strengthens gut barrier, modulates cytokine profile Reduced IBS symptoms and inflammatory markers (Ducrotté et al., 2012) [8] Gut barrier, inflammation
7 Lactobacillus acidophilus NCFM B Enhances Th1 responses, increases IL-12 production Reduced cold/flu symptom duration by 48% when combined with B. lactis Bi-07 [9] Respiratory infections

Evidence grades: A = Multiple RCTs or meta-analyses with consistent results; B+ = Multiple RCTs with strong results; B = RCTs with consistent but limited results

Note on Lactobacillus casei Shirota: This strain also has clinical evidence for immune modulation, particularly enhanced NK cell activity in elderly populations (Takeda et al., 2006). However, it is available primarily through Yakult fermented milk rather than standalone supplements, limiting its practical application in dosing protocols [10].

How Does Each Immune Probiotic Strain Work?

Each probiotic strain activates different arms of the immune system through distinct molecular mechanisms — understanding these pathways helps you choose the right strain for your specific immune goals. The gut-associated lymphoid tissue (GALT) houses 70% of your immune cells, and probiotic strains interact with this tissue through pattern recognition receptors, epithelial cell signaling, and direct immune cell modulation [11].

Lactobacillus rhamnosus GG (LGG)

LGG is the world’s most-studied probiotic strain, with over 1,500 published studies and 40+ clinical trials specifically examining immune function. Its pili (hair-like surface structures) bind directly to intestinal epithelial cells and dendritic cells, triggering a cascade of immune responses [2].

Mechanism Detail Clinical Significance
IgA stimulation Increases secretory IgA at mucosal surfaces First-line defense against respiratory and gut pathogens
Macrophage activation Upregulates phagocytic activity via TLR2 signaling Enhanced pathogen clearance
Gut barrier strengthening Increases tight junction protein expression (ZO-1, occludin) Prevents pathogen translocation
Th1/Th2 balance Promotes balanced Th1 response without excessive inflammation Appropriate immune activation without overreaction
Anti-inflammatory signaling Induces IL-10 production while modulating IL-6, TNF-α Controls inflammation while maintaining immune readiness

Clinical highlight: In a 2010 RCT, children receiving LGG (10⁹ CFU/day) for 3 months had 34% fewer respiratory infections and significantly fewer days with respiratory symptoms compared to placebo [2].

Bifidobacterium animalis subsp. lactis BB-12

BB-12 is the most-documented Bifidobacterium strain in the world, with over 300 scientific publications. It is particularly effective at enhancing natural killer (NK) cell activity and improving vaccine responses — making it especially valuable for elderly populations whose immune function declines with age [3].

Mechanism Detail Clinical Significance
NK cell enhancement Increases NK cell cytotoxic activity Improved viral defense and tumor surveillance
Phagocyte activation Enhances neutrophil and macrophage phagocytosis Faster pathogen elimination
Vaccine adjuvant effect Increases antibody response to influenza vaccine Better protection from vaccination
Cytokine modulation Stimulates IFN-γ and IL-12 (Th1 response) Promotes antiviral immune profile
Gut microbiome diversity Increases beneficial Bifidobacterium populations Broader ecosystem-level immune support

Clinical highlight: Elderly nursing home residents receiving BB-12 combined with LGG showed trends toward improved immune biomarkers, though a large 2021 PRINCESS trial found limited effects on some inflammatory markers in institutionalized elderly — suggesting earlier intervention may be more beneficial [12].

Bifidobacterium animalis subsp. lactis HN019

HN019 stands out for producing some of the most dramatic immune biomarker changes observed in probiotic clinical trials, particularly in elderly populations. A landmark study found significant increases in both NK cell activity and neutrophil phagocytic capacity within just 3 weeks [4].

Mechanism Detail Clinical Significance
NK cell activation Dose-dependent increase in NK cell tumoricidal activity Enhanced innate viral/tumor defense
Neutrophil phagocytosis Significant increase in phagocytic capacity Improved bacterial clearance
Anti-inflammatory modulation Modulates immune system toward anti-inflammatory action Reduced chronic low-grade inflammation [13]
Pathogen exclusion Excludes enteropathogenic adhesion to epithelial cells Competitive inhibition of harmful bacteria

Clinical highlight: In a 2001 RCT of elderly subjects (age 63–84), those receiving HN019 (5 × 10⁹ CFU/day) for 3 weeks showed significant increases in total and helper (CD4+) T lymphocytes, NK cells, and phagocytic cell activity [4].

Bifidobacterium animalis subsp. lactis Bl-04

Bl-04 has emerged as a particularly promising strain for active adults and athletes, with clinical evidence showing significant reductions in upper respiratory tract infections (URTIs) in physically active populations. A 2024 in vitro study revealed that Bl-04 modulates antiviral immune responses by potentiating cytokine production during viral challenge in immune cells [5][14].

Mechanism Detail Clinical Significance
Antiviral innate response Modulates macrophage and dendritic cell cytokine production during viral challenge Enhanced first-line antiviral defense
Nasal mucosal immunity Affects innate immunity in nasal mucosa, reduces nasal viral titers Direct respiratory protection
IFN-γ stimulation Enhances interferon-gamma production Improved antiviral signaling

Clinical highlight: Physically active adults receiving Bl-04 (2 × 10⁹ CFU/day) for 150 days had a 27% lower risk of URTI episodes compared to placebo (West et al., 2014) [5].

Saccharomyces boulardii CNCM I-745

S. boulardii is unique among immune probiotics — it’s a yeast, not a bacterium. This gives it natural resistance to antibiotics, making it the only probiotic that can be taken alongside antibiotic therapy without being killed. Its immune mechanisms focus on stimulating intestinal immunoglobulin A and modulating gut-associated immune signaling [6][7].

Mechanism Detail Clinical Significance
IgA stimulation 4.4-fold increase in intestinal anti-toxin A IgA levels Enhanced mucosal immune defense
Immunoglobulin induction Induces release of immunoglobulins and cytokines Broad humoral immune activation
Anti-inflammatory Attenuates inflammatory responses via TLR4/TLR15-MyD8 pathway Controlled inflammation during infection
Antibiotic-resistant Survives concurrent antibiotic use Only probiotic effective during antibiotic therapy
Pathogen toxin neutralization Produces proteases that degrade C. difficile toxins Direct pathogen defense

Clinical highlight: A meta-analysis of 27 RCTs encompassing 5,029 patients found S. boulardii was significantly efficacious and safe in 84% of treatment arms, with particular strength in preventing antibiotic-associated diarrhea and C. difficile infection [7].

Lactobacillus plantarum 299v

L. plantarum 299v works primarily through gut barrier reinforcement and anti-inflammatory cytokine modulation. While its immune evidence is less focused on respiratory infections, it plays an important role in reducing gut inflammation and maintaining barrier integrity — both critical for the 70% of immune tissue that resides in the gut [8].

Mechanism Detail Clinical Significance
Gut barrier integrity Increases mucin production and tight junction proteins Prevents systemic immune activation from gut leakage
Cytokine modulation Reduces pro-inflammatory IL-6 and TNF-α Controls chronic low-grade inflammation
Iron absorption Enhances non-heme iron absorption by 50% Prevents iron-deficiency-related immune impairment

Lactobacillus acidophilus NCFM

NCFM enhances Th1 immune responses and has shown particular promise when combined with Bifidobacterium strains for respiratory infection prevention [9].

Mechanism Detail Clinical Significance
Th1 enhancement Increases IL-12 production, promotes Th1 response Strengthens antiviral immune profile
Dendritic cell activation Activates dendritic cells via surface layer proteins Bridges innate and adaptive immunity
Synergistic effects Enhanced benefits when combined with B. lactis Bi-07 48% reduction in cold/flu symptom duration

What Are the Correct Dosing Protocols by Population?

Probiotic dosing for immune support varies significantly by age, health status, and specific immune goals — a healthy adult maintaining general immunity needs a different protocol than an elderly person preparing for flu season or an athlete in heavy training. The protocols below are derived from the dosages used in successful clinical trials.

General Adult Protocol (Ages 18–60)

Purpose Strain(s) Daily Dose Duration Evidence
General immune maintenance LGG + BB-12 10–20 billion CFU Ongoing Multiple RCTs
Respiratory infection prevention LGG or Bl-04 10 billion CFU 3–7 months (seasonal) Hojsak 2010 [2], West 2014 [5]
During/after antibiotic use S. boulardii 500mg (10 billion CFU) 2x/day Duration of antibiotics + 2 weeks Meta-analysis [7]
Gut barrier support L. plantarum 299v 10–20 billion CFU 4–8 weeks minimum Ducrotté 2012 [8]
Cold/flu acute support L. acidophilus NCFM + B. lactis Bi-07 10 billion CFU combined Through illness + 1 week Leyer et al. 2009 [9]

Children’s Protocol (Ages 1–17)

Purpose Strain(s) Daily Dose Duration Evidence
Respiratory infection prevention LGG 5–10 billion CFU (10⁹) 3 months minimum Hojsak 2010 [2]
General immune support LGG + BB-12 5–10 billion CFU Ongoing Multiple pediatric RCTs
Antibiotic-associated diarrhea prevention S. boulardii 250–500mg (5–10 billion CFU) Duration + 1 week Cochrane review
Daycare/school illness prevention LGG 10 billion CFU Fall–spring seasonal Hojsak 2010 [2]

Pediatric note: LGG and BB-12 have the most extensive safety data in children. Always use age-appropriate formulations (powder or drops for young children). Consult a pediatrician for children under 1 year.

Elderly Protocol (Ages 60+)

Purpose Strain(s) Daily Dose Duration Evidence
Age-related immune decline B. lactis HN019 5–10 billion CFU (5 × 10⁹) Ongoing (minimum 3 weeks) Gill 2001 [4]
NK cell activation HN019 or BB-12 10 billion CFU 6+ weeks Multiple RCTs
Pre-vaccination boost BB-12 10 billion CFU Start 2–4 weeks before vaccination Akatsu 2013 [3]
General immune maintenance LGG + BB-12 + HN019 15–20 billion CFU combined Ongoing Multiple RCTs
Antibiotic recovery S. boulardii 500mg 2x/day Duration + 2 weeks Meta-analysis [7]

Elderly note: HN019 has shown the most dramatic improvements in elderly immune biomarkers (NK cells, T lymphocytes, phagocytic capacity) within 3 weeks [4]. Starting probiotic supplementation before flu season or planned vaccinations produces the strongest benefits.

Athlete Protocol (High Training Load)

Purpose Strain(s) Daily Dose Duration Evidence
URTI prevention during heavy training B. lactis Bl-04 2 billion CFU (2 × 10⁹) Training season (5+ months) West 2014 [5]
General immune resilience LGG + Bl-04 20–50 billion CFU combined Ongoing during training Multiple athlete studies
Competition/race preparation Multi-strain (LGG + BB-12 + Bl-04) 30–50 billion CFU Start 4–6 weeks before event Expert consensus
Post-competition recovery Multi-strain 20–50 billion CFU 2–4 weeks post-event Expert consensus

Athlete note: Intense exercise temporarily suppresses mucosal immunity and increases URTI risk (the “open window” hypothesis). Bl-04 specifically targets nasal mucosal immunity, making it uniquely suited for athletes [5][14].

How Do You Choose a Quality Immune Probiotic Product?

The probiotic supplement market is notoriously inconsistent — studies have found that up to 43% of products don’t contain the strains or quantities listed on their labels. Choosing a quality product requires understanding strain specificity, third-party testing, and formulation science [15].

Quality Selection Criteria

Criterion What to Look For Red Flag
Strain specificity Full strain designation (e.g., “L. rhamnosus GG” not just “L. rhamnosus”) Only lists genus and species without strain
CFU guarantee “Guaranteed through expiration” not “at time of manufacture” Only guarantees CFU at manufacture
Third-party testing USP, NSF, ConsumerLab, or ISAPP verified No independent verification
Storage requirements Clear storage instructions; refrigerated or shelf-stable formulation No storage guidance
Clinical evidence Uses strains with published human clinical trials Proprietary blends with no clinical data
Delivery technology Acid-resistant capsule or proven survival technology No information on gastric survival
Allergen transparency Clear allergen labeling; dairy-free if relevant Vague “may contain” statements
Expiration date Clear date with viability guarantee No expiration or “best by” date

Probiotic Formulation Comparison

Format Pros Cons Best For
Capsules (enteric-coated) Best gastric acid survival, precise dosing, portable More expensive Adults, daily maintenance
Powder sachets Easy to mix, flexible dosing, good for children Exposure to moisture risk Children, elderly who can’t swallow capsules
Fermented foods Multiple strains, additional nutrients, food matrix Variable CFU counts, unpredictable strains General microbiome diversity
Drops Precise pediatric dosing, easy administration Limited strain options, shorter shelf life Infants and toddlers
Chewables Kid-friendly, no swallowing needed Sugar content, heat sensitivity Children ages 3+

What to Avoid

What Does the Clinical Research Actually Show?

The clinical evidence for probiotic immune benefits has matured significantly, with Cochrane reviews, large-scale RCTs, and mechanistic studies providing a clearer picture than existed a decade ago. Below are the most important clinical findings organized by outcome.

Respiratory Infection Prevention

Study Design Strain(s) Population Key Finding
Hao et al., 2015 [1] Cochrane review, 12 RCTs Various Lactobacillus/Bifidobacterium 3,720 participants 47% reduction in URTI incidence; 1.89 days shorter duration; 35% less antibiotic use
Hojsak et al., 2010 [2] RCT, double-blind LGG (10⁹ CFU/day) 281 children in daycare 34% fewer respiratory infections over 3 months
West et al., 2014 [5] RCT, double-blind Bl-04 (2 × 10⁹ CFU/day) 465 physically active adults 27% lower URTI risk over 150 days
Leyer et al., 2009 [9] RCT, double-blind L. acidophilus NCFM + B. lactis Bi-07 326 children ages 3–5 48% reduction in cold/flu symptom duration; 84% less antibiotic use

Immune Biomarker Enhancement

Study Design Strain(s) Population Key Finding
Gill et al., 2001 [4] RCT HN019 (5 × 10⁹ CFU/day) 30 elderly adults (63–84) Significant increases in NK cells, CD4+ T cells, phagocytic capacity in 3 weeks
Akatsu et al., 2013 [3] RCT BB-12 Elderly nursing home residents Enhanced influenza vaccine antibody response
Takeda et al., 2006 [10] RCT L. casei Shirota Elderly Increased NK cell activity after 4 weeks

Gut Immune Function

Study Design Strain(s) Population Key Finding
McFarland, 2010 [7] Meta-analysis, 27 RCTs S. boulardii 5,029 patients 84% efficacy across treatment arms; significant for AAD and C. difficile prevention
Qamar et al., 2001 [6] Controlled trial S. boulardii Mouse model 4.4-fold increase in intestinal anti-toxin A IgA levels
Ducrotté et al., 2012 [8] RCT L. plantarum 299v 214 IBS patients Significant reduction in symptoms and inflammatory markers

How Do Probiotics Interact With Your Immune System?

Probiotic bacteria communicate with your immune system through a sophisticated molecular dialogue at the gut mucosal surface — interacting with epithelial cells, dendritic cells, and lymphocytes through pattern recognition receptors and metabolite signaling. This cross-talk sustains the balance between immune tolerance (not attacking food and commensal bacteria) and immunogenicity (mounting responses against pathogens) [11].

Key Immune Interaction Pathways

Pathway Mechanism Probiotic Strains Involved Immune Outcome
TLR2/TLR4 signaling Probiotic cell wall components activate toll-like receptors on dendritic cells LGG, L. plantarum, S. boulardii Cytokine cascade, immune cell activation
IgA induction Stimulates B cells in Peyer’s patches to produce secretory IgA LGG, S. boulardii, BB-12 Enhanced mucosal defense
NK cell activation Probiotic metabolites and cell components enhance NK cell cytotoxicity HN019, BB-12, L. casei Shirota Improved antiviral and antitumor surveillance
Th1/Th2 balance Promotes appropriate Th1 responses without suppressing Th2 LGG, NCFM, BB-12 Balanced immune activation
Tight junction regulation Increases expression of ZO-1, occludin, claudin proteins LGG, L. plantarum 299v Prevents “leaky gut” and systemic inflammation
Short-chain fatty acid (SCFA) production Produces butyrate, propionate, acetate that fuel colonocytes and immune cells Multiple Bifidobacterium spp. Anti-inflammatory, energy supply to gut immune cells
Competitive exclusion Physical competition for adhesion sites on epithelial cells HN019, LGG, L. plantarum Prevents pathogen colonization [13]

The Gut-Immune Axis: Why 70% of Immunity Lives in Your Gut

The gut-associated lymphoid tissue (GALT) is the largest immune organ in your body. It contains:

Probiotics interact with all of these components, which is why strain selection and consistent dosing produce measurable systemic immune effects — not just local gut improvements [11].

What Are the Safety Considerations and Contraindications?

Most well-studied probiotic strains have excellent safety profiles, with adverse events in clinical trials comparable to placebo. However, specific populations need extra caution.

Population Safety Status Cautions
Healthy adults Generally Recognized as Safe (GRAS) Mild bloating/gas may occur during first week
Children (1+) Safe for well-studied strains (LGG, BB-12) Use age-appropriate doses and formulations
Elderly Safe; significant benefits documented Start with lower doses, increase gradually
Pregnant/breastfeeding LGG and BB-12 considered safe Consult healthcare provider; avoid S. boulardii
Immunocompromised ⚠️ Caution required Rare cases of fungemia with S. boulardii in severely ill ICU patients; consult provider [7]
Central venous catheter patients ⚠️ Avoid S. boulardii Risk of catheter colonization

Drug Interactions

Medication Interaction Recommendation
Antibiotics Kill bacterial probiotics Take probiotics 2+ hours away from antibiotics; S. boulardii is antibiotic-resistant
Antifungals Kill S. boulardii Do not combine antifungals with S. boulardii
Immunosuppressants Theoretical risk of probiotic translocation Consult healthcare provider before use
## Frequently Asked Questions **Q: Which probiotic strains have the strongest evidence for immune support?** **A:** Lactobacillus rhamnosus GG (LGG), Bifidobacterium animalis subsp. lactis (BB-12, HN019, Bl-04), and Saccharomyces boulardii CNCM I-745 have the strongest clinical evidence. A 2015 Cochrane review of 12 RCTs found probiotics reduced upper respiratory infection incidence by 47% and antibiotic use by 35% compared to placebo [1]. **Q: How much probiotic should I take for immune health?** **A:** For general immune support in adults, clinical trials typically use 10–50 billion CFU daily of multi-strain formulas or specific single strains. LGG is effective at 10 billion CFU daily, while B. lactis BB-12 shows benefits at 1–10 billion CFU. Dosing varies by population: children typically need 5–10 billion CFU, elderly adults 10–20 billion CFU, and athletes 20–50 billion CFU daily. **Q: Can probiotics help prevent respiratory infections?** **A:** Yes. A Cochrane systematic review (Hao et al., 2015) analyzing 12 randomized controlled trials found that probiotics reduced the number of participants experiencing acute upper respiratory tract infections by 47%, shortened infection duration by approximately 1.89 days, and reduced antibiotic prescription rates by 35% [1]. **Q: What is the difference between Lactobacillus and Bifidobacterium for immunity?** **A:** Lactobacillus strains (like LGG and L. plantarum) primarily enhance innate immune responses by stimulating macrophage activity, increasing IgA production, and strengthening gut barrier function. Bifidobacterium strains (like BB-12 and HN019) tend to modulate adaptive immunity by enhancing NK cell activity, increasing anti-inflammatory cytokines, and improving vaccine responses. Both genera work synergistically when combined. **Q: Are probiotics safe for children and elderly adults?** **A:** Most well-studied probiotic strains are considered safe for both children and elderly adults. LGG and BB-12 have extensive safety data in pediatric populations. For elderly adults, B. lactis HN019 has shown particular benefits for age-related immune decline. However, immunocompromised individuals should consult a healthcare provider before starting probiotics, as rare cases of fungemia have been reported with S. boulardii in severely ill patients [7]. **Q: How long does it take for probiotics to improve immune function?** **A:** Clinical trials show measurable immune changes within 2–4 weeks of consistent probiotic use, with full benefits typically observed at 6–12 weeks. A study on B. lactis HN019 found significant increases in NK cell activity and neutrophil phagocytic capacity within 3 weeks [4]. For respiratory infection prevention, most trials showing benefit lasted 3–7 months. **Q: Should I take probiotics with or without food for immune benefits?** **A:** Most probiotic strains survive better when taken with or just before a meal containing some fat. A 2011 study found that probiotic survival was highest when taken with a meal or 30 minutes before eating [16]. However, Saccharomyces boulardii is acid-resistant and can be taken regardless of meals. Consistency of daily intake matters more than exact timing.

Curated Research Database

Key meta-analyses, RCTs, and mechanistic studies organized by research category.

Meta-Analyses & Systematic Reviews

Study Journal/Year Key Finding Population
Hao et al. Cochrane, 2015 Probiotics reduced URTI incidence by 47%, duration by 1.89 days 3,720 participants, 12 RCTs [1]
McFarland World J Gastroenterol, 2010 S. boulardii efficacious in 84% of 27 RCT treatment arms 5,029 patients [7]
Wang et al. Medicine, 2016 Probiotics reduced common cold duration by 1.89 days Meta-analysis
King et al. Br J Nutr, 2014 Probiotics reduced URTI incidence and severity in physically active Systematic review

Randomized Controlled Trials

Study Journal/Year Key Finding Population
Gill et al. Am J Clin Nutr, 2001 HN019 increased NK cells, CD4+ T cells in 3 weeks 30 elderly adults [4]
Hojsak et al. Pediatrics, 2010 LGG reduced respiratory infections by 34% in children 281 children [2]
West et al. Clin Nutr, 2014 Bl-04 reduced URTI risk by 27% in active adults 465 adults [5]
Leyer et al. Pediatrics, 2009 NCFM + Bi-07 reduced cold/flu duration 48%, antibiotics 84% 326 children [9]
Akatsu et al. 2013 BB-12 enhanced influenza vaccine response in elderly Elderly residents [3]
Takeda et al. Eur J Clin Nutr, 2006 L. casei Shirota increased NK cell activity in elderly Elderly adults [10]
Ducrotté et al. WJG, 2012 L. plantarum 299v reduced IBS symptoms 214 adults [8]

Mechanistic & In Vitro Studies

Study Journal/Year Key Finding
Mazziotta et al. Cells, 2023 Comprehensive review of probiotic mechanisms on immune cells [11]
Heliyon (Bl-04) Heliyon, 2024 Bl-04 modulates antiviral innate responses in macrophages/DCs [14]
Gopal et al. FEMS, 2001 HN019 modulates immune system toward anti-inflammatory action [13]
Qamar et al. Infect Immun, 2001 S. boulardii stimulates 4.4-fold IgA increase [6]
Kelesidis & Pothoulakis Therap Adv Gastroenterol, 2012 S. boulardii mechanisms of action review [17]

References

  1. Hao Q, et al. “Probiotics for preventing acute upper respiratory tract infections.” Cochrane Database Syst Rev. 2015;(2):CD006895. https://doi.org/10.1002/14651858.CD006895.pub3
  2. Hojsak I, et al. “Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers.” Pediatrics. 2010;125(5):e1171-e1177. https://doi.org/10.1542/peds.2009-2568
  3. Akatsu H, et al. “Enhanced vaccination effect against influenza by administration of Bifidobacterium-fermented milk to elderly.” 2013.
  4. Gill HS, et al. “Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.” Am J Clin Nutr. 2001;74(6):833-839. https://doi.org/10.1093/ajcn/74.6.833
  5. West NP, et al. “Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.” Clin Nutr. 2014;33(4):581-587. https://doi.org/10.1016/j.clnu.2013.10.002
  6. Qamar A, et al. “Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice.” Infect Immun. 2001;69(4):2762-2765. https://doi.org/10.1128/IAI.69.4.2762-2765.2001
  7. McFarland LV. “Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.” World J Gastroenterol. 2010;16(18):2202-2222. https://doi.org/10.3748/wjg.v16.i18.2202
  8. Ducrotté P, et al. “Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.” World J Gastroenterol. 2012;18(30):4012-4018. https://doi.org/10.3748/wjg.v18.i30.4012
  9. Leyer GJ, et al. “Probiotic effects on cold and influenza-like symptom incidence and duration in children.” Pediatrics. 2009;124(2):e172-e179. https://doi.org/10.1542/peds.2008-2666
  10. Takeda K, et al. “Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity.” Eur J Clin Nutr. 2006;60:1211-1217. https://doi.org/10.1038/sj.ejcn.1602456
  11. Mazziotta C, et al. “Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health.” Cells. 2023;12(1):184. https://doi.org/10.3390/cells12010184
  12. Allen SJ, et al. “The PRINCESS trial: Probiotics to reduce infections in care home elderly.” Frontiers in Immunology. 2021. https://doi.org/10.3389/fimmu.2021.643321
  13. Gopal PK, et al. “Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.” FEMS Immunol Med Microbiol. 2001. https://doi.org/10.1111/j.1574-695X.2001.tb01565.x
  14. Heliyon. “The effect of probiotic Bifidobacterium lactis Bl-04 on innate antiviral responses in vitro.” Heliyon. 2024;10(5):e26996. https://doi.org/10.1016/j.heliyon.2024.e26996
  15. Labdoor. “Probiotic Rankings.” 2024. https://labdoor.com/rankings/probiotics
  16. Tompkins TA, et al. “The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract.” Benef Microbes. 2011;2(4):295-303. https://doi.org/10.3920/BM2011.0022
  17. Kelesidis T, Pothoulakis C. “Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.” Therap Adv Gastroenterol. 2012;5(2):111-125. https://doi.org/10.1177/1756283X11428502
  18. Wiertsema SP, et al. “The Interplay between the Gut Microbiome and the Immune System.” Nutrients. 2021;13(3):886. https://doi.org/10.3390/nu13030886
  19. Gombart AF, et al. “A Review of Micronutrients and the Immune System.” Nutrients. 2020;12(1):236. https://doi.org/10.3390/nu12010236
  20. Jungersen M, et al. “The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12.” Microorganisms. 2014;2(2):92-110. https://doi.org/10.3390/microorganisms2020092

Free Tools & Checklists

📋 Free Tools: Download our 🛡️ Immune System Daily Checklist — a free, interactive daily habits tracker including probiotic protocols based on this research.

Further Reading

📚 On this site:

📖 Full guides on HealthSecrets.com:

© HealthSecrets.com — Evidence-based immune probiotic strains guide. For educational purposes only. The information provided does not constitute medical advice. Consult a qualified healthcare professional before starting any supplement protocol.